Benchmark Downgrades Nephros (NEPH) to Hold
Tweet
Share
E-mailGet Alerts NEPH Hot Sheet
Price: $4.27 --0%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 15 | New: 6
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 15 | New: 6
Join SI Premium – FREE
Benchmark analyst Robert Wasserman downgraded Nephros (NASDAQ: NEPH) from Speculative Buy to Hold.
For an analyst ratings summary and ratings history on Nephros click here. For more ratings news on Nephros click here.
Shares of Nephros closed at $2.21 yesterday.
You May Also Be Interested In
- BofA Securities Downgrades Bending Spoons (BSP) to Underperform
- ICICI Securities Downgrades Astra Microwave Products (ASTM:IN) to Hold (3)
- China Merchants Securities Downgrades Tencent Music Entertainment Group (TME) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
